相似文献
1
Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys.
Am J Respir Crit Care Med. 2004 Dec 1;170(11):1153-7. doi: 10.1164/rccm.200404-533OC. Epub 2004 Aug 11.
2
Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma.
Int Immunopharmacol. 2004 Jan;4(1):127-38. doi: 10.1016/j.intimp.2003.11.005.
3
Histopathologic and morphometric evaluation of the nasal and pulmonary airways of cats with experimentally induced asthma.
Int Arch Allergy Immunol. 2013;160(4):365-76. doi: 10.1159/000342992. Epub 2012 Nov 22.
4
The pathophysiology of asthma.
Can Med Assoc J. 1979 Aug 18;121(4):409-14.
5
Effects of concentrated ambient particles on normal and hypersecretory airways in rats.
Res Rep Health Eff Inst. 2004 Aug(120):1-68; discussion 69-79.
6
Effects of an antibody to interleukin-5 in a monkey model of asthma.
Am J Respir Crit Care Med. 1995 Aug;152(2):467-72. doi: 10.1164/ajrccm.152.2.7633694.
7
The non-human primate as a model for studying COPD and asthma.
Pulm Pharmacol Ther. 2008 Oct;21(5):755-66. doi: 10.1016/j.pupt.2008.01.008. Epub 2008 Feb 1.
8
Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness.
Am J Respir Crit Care Med. 2010 Jan 15;181(2):106-15. doi: 10.1164/rccm.200904-0631OC. Epub 2009 Oct 29.
9
[The relation between morphologic and functional airway changes in bronchial asthma].
Verh K Acad Geneeskd Belg. 2003;65(4):247-65; discussion 265-9.
10
Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome.
Int Immunopharmacol. 2015 Sep;28(1):390-8. doi: 10.1016/j.intimp.2015.06.028. Epub 2015 Jul 9.
引用本文的文献
1
CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance.
Front Immunol. 2021 Feb 23;12:590054. doi: 10.3389/fimmu.2021.590054. eCollection 2021.
2
Pulmonary Consequences of Prenatal Inflammatory Exposures: Clinical Perspective and Review of Basic Immunological Mechanisms.
Front Immunol. 2020 Jun 19;11:1285. doi: 10.3389/fimmu.2020.01285. eCollection 2020.
3
Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.
J Innate Immun. 2020;12(3):203-225. doi: 10.1159/000502489. Epub 2019 Sep 17.
4
The crosstalk between microbiome and asthma: Exploring associations and challenges.
Clin Exp Allergy. 2019 Aug;49(8):1067-1086. doi: 10.1111/cea.13444. Epub 2019 Jun 27.
5
Nonhuman Primate Models of Respiratory Disease: Past, Present, and Future.
ILAR J. 2017 Dec 1;58(2):269-280. doi: 10.1093/ilar/ilx030.
6
Development of a novel severe triple allergen asthma model in mice which is resistant to dexamethasone and partially resistant to TLR7 and TLR9 agonist treatment.
PLoS One. 2014 Mar 11;9(3):e91223. doi: 10.1371/journal.pone.0091223. eCollection 2014.
7
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice.
Thorax. 2014 Jun;69(6):565-573. doi: 10.1136/thoraxjnl-2013-204605. Epub 2014 Jan 24.
8
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis.
Respir Res. 2012 Jun 22;13(1):53. doi: 10.1186/1465-9921-13-53.
9
Pattern-recognition receptors in human eosinophils.
Immunology. 2012 May;136(1):11-20. doi: 10.1111/j.1365-2567.2012.03556.x.
10
Lung gene expression in a rhesus allergic asthma model correlates with physiologic parameters of disease and exhibits common and distinct pathways with human asthma and a mouse asthma model.
Am J Pathol. 2011 Oct;179(4):1667-80. doi: 10.1016/j.ajpath.2011.06.009. Epub 2011 Aug 3.
本文引用的文献
1
Immunostimulatory DNA inhibits transforming growth factor-beta expression and airway remodeling.
Am J Respir Cell Mol Biol. 2004 May;30(5):651-61. doi: 10.1165/rcmb.2003-0066OC. Epub 2003 Nov 14.
2
Repeated episodes of ozone inhalation amplifies the effects of allergen sensitization and inhalation on airway immune and structural development in Rhesus monkeys.
Toxicol Appl Pharmacol. 2003 Aug 15;191(1):74-85. doi: 10.1016/s0041-008x(03)00218-7.
3
Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure.
Am J Physiol Lung Cell Mol Physiol. 2003 Nov;285(5):L1137-46. doi: 10.1152/ajplung.00073.2003. Epub 2003 Jul 11.
4
Resolution of airway inflammation following ovalbumin inhalation: comparison of ISS DNA and corticosteroids.
Am J Respir Cell Mol Biol. 2003 Jun;28(6):655-63. doi: 10.1165/rcmb.4853.
5
Airway remodeling in asthma.
Chest. 2003 Mar;123(3 Suppl):417S-22S. doi: 10.1378/chest.123.3_suppl.417s.
6
Biological activity of immunostimulatory CpG DNA motifs in domestic animals.
Vet Immunol Immunopathol. 2003 Jan 30;91(2):89-103. doi: 10.1016/s0165-2427(02)00246-5.
7
Fibroblast growth factor-2 in remodeling of the developing basement membrane zone in the trachea of infant rhesus monkeys sensitized and challenged with allergen.
Lab Invest. 2002 Dec;82(12):1747-54. doi: 10.1097/01.lab.0000043911.94235.f3.
8
CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma.
J Allergy Clin Immunol. 2002 Dec;110(6):867-72. doi: 10.1067/mai.2002.129371.
9
Treatment of established asthma in a murine model using CpG oligodeoxynucleotides.
Am J Physiol Lung Cell Mol Physiol. 2002 Jul;283(1):L170-9. doi: 10.1152/ajplung.00402.2001.
10
Toll-like receptors and innate immunity.
Nat Rev Immunol. 2001 Nov;1(2):135-45. doi: 10.1038/35100529.
Zotero 插件